This confirmed the disruption of the BCL11B locus at 14q32 and suggested the presence of a novel ETP-ALL oncogene located at 2q22 in these two immature/ETP-ALL patients. This evidence concerns the gene BCL11B and acute lymphoblastic leukemia.